Endocrine oncology

Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study

Eur J EndocrinolPublished Histopathological cohort study

Authors' conclusion

Detailed reexamination of lymph nodes revealed that only the presence of more than 5 lymph node metastases was an independent predictor of failure to achieve a complete response to treatment. No predictive value was found for other histopathological features, including the diameter of the lymph node metastases. These findings have the potential to improve risk stratification in patients with PTC and clinically evident lymph node metastases.

Study context

Population
Papillary thyroid cancer (PTC) patients with clinically evident lymph node metastases1,042 lymph node metastases
Participants
129 patients
Exposure
>5 lymph node metastases vs ≤5
Outcome
Failure to achieve a complete biochemical and structural response to treatment
Methodological detailspredefined reexamination protocol
  • Predefined reexamination protocol

Main finding

As reported in the abstract

Failure to achieve complete response to treatment
  • More than 5 lymph node metastases: only independent predictor, OR 3.39 (95% CI 1.57-7.33), P < .05
  • Diameter nor any of the other evaluated lymph node features (extranodal extension, cystic changes, necrosis, calcifications, proportion of node taken up by tumor) were significantly associated with response to treatment

Observational data: associations, not effects.

Original publication

Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study. Eur J Endocrinol. Published 23 April 2024. doi:10.1093/ejendo/lvae048

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.